Home > News > US-based CytImmune gears up to target cancer cure
June 18th, 2007
US-based CytImmune gears up to target cancer cure
Abstract:
We all know there is no magic bullet for cancer. But scientists across the world are working on novel projects like cancer vaccines and newer tools like nanotechnology to conquer cancer, reports CNBC-TV18.
CytImmune is a small US-based nanotechnology company, but it has set a big goal for itself. CytImmune scientists are developing a nanotechnology-based Drug Delivery System that can target cancerous tumours leaving healthy organs and tissues untouched.
Source:
moneycontrol.com
Bookmark:
Nanomedicine
Nanoparticle Delivers Large Protein Complex to Cancer Cell Nucleus May 20th, 2013
Protein 'Passport' Helps Nanoparticles Get Past Immune System May 20th, 2013
New Nanopore Sensor Simplifies Analysis of Methylated DNA May 20th, 2013
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals
International survey supports need for built-in water protection on smartphones and tablets May 21st, 2013
Rice unveils method for tailoring optical processors: Arranging nanoparticles in geometric patterns allows for control of light with light May 21st, 2013
Protein 'Passport' Helps Nanoparticles Get Past Immune System May 20th, 2013
Nanoparticle Harnesses Powerful Radiation Therapy for Cancer May 20th, 2013